GSN Gene Amyloidosis Finnish Type NGS Genetic DNA Test
Comprehensive Genetic Testing for Finnish Type Amyloidosis
The GSN Gene Amyloidosis Finnish Type NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the GSN (gelsolin) gene associated with Finnish type hereditary amyloidosis. This progressive neurological disorder, also known as Meretoja syndrome, is characterized by the abnormal accumulation of amyloid proteins in various tissues, leading to systemic complications and progressive nerve damage.
What This Advanced Genetic Test Detects
Our state-of-the-art Next-Generation Sequencing (NGS) technology provides comprehensive analysis of the GSN gene to identify pathogenic variants responsible for Finnish type amyloidosis. The test specifically examines:
- Complete GSN gene sequencing for mutation detection
- Identification of specific Finnish-type amyloidosis variants
- Assessment of amyloid protein deposition risk factors
- Genetic markers associated with neurological symptom progression
- Inheritance pattern analysis for family planning
Who Should Consider This Genetic Test?
This specialized genetic screening is recommended for individuals experiencing symptoms or having risk factors for Finnish type amyloidosis, including:
Symptoms and Clinical Indications
- Progressive cranial neuropathy with facial weakness
- Lattice corneal dystrophy affecting vision
- Cutis laxa (loose, sagging skin)
- Peripheral neuropathy with sensory disturbances
- Cardiac conduction abnormalities
- Renal dysfunction and proteinuria
- Family history of Finnish ancestry with similar symptoms
- Unexplained progressive neurological symptoms
High-Risk Populations
- Individuals of Finnish descent with family history of amyloidosis
- Patients with unexplained progressive neurological symptoms
- Family members of diagnosed Finnish type amyloidosis patients
- Individuals planning pregnancy with family history of the condition
Significant Benefits of Early Genetic Detection
Early identification through the GSN Gene Amyloidosis Finnish Type NGS Genetic DNA Test provides numerous clinical advantages:
Proactive Medical Management
- Enables early intervention and symptom management
- Facilitates targeted monitoring for disease progression
- Allows for personalized treatment planning
- Supports comprehensive multidisciplinary care coordination
Family Planning and Genetic Counseling
- Provides accurate genetic risk assessment for family members
- Supports informed reproductive decision-making
- Enables preimplantation genetic diagnosis options
- Facilitates cascade testing within affected families
Understanding Your Test Results
Our comprehensive genetic counseling ensures you fully understand your test outcomes and their implications:
Positive Result Interpretation
- Confirmation of GSN gene mutation associated with Finnish type amyloidosis
- Detailed explanation of inheritance patterns and family risk
- Personalized management recommendations based on specific mutation
- Referral to appropriate specialists for comprehensive care
Negative Result Interpretation
- Exclusion of common Finnish type amyloidosis mutations
- Discussion of residual risk for other genetic conditions
- Guidance on alternative diagnostic approaches if symptoms persist
- Reassurance for family planning decisions
Variant of Uncertain Significance (VUS)
- Explanation of genetic variants with unclear clinical significance
- Recommendations for family studies to clarify variant interpretation
- Ongoing monitoring as genetic knowledge evolves
- Periodic re-evaluation of variant classification
Test Pricing and Service Details
| Service | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Service Specifications
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
- Pre-test Requirements: Clinical History and Genetic Counseling Session
- Specialty: Neurology and Genetics
- Testing Method: Next-Generation Sequencing (NGS) Technology
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.
Take Control of Your Neurological Health Today
Don’t let uncertainty about genetic risks affect your quality of life. The GSN Gene Amyloidosis Finnish Type NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. Our expert team is ready to guide you through the testing process with compassion and professional excellence.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Take the first step toward understanding your genetic health and securing your neurological future.
